Schroder Investment Management Group
IBB icon

Schroder Investment Management Group’s iShares Biotechnology ETF IBB Stock Holding History

Schroder Investment Management Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-75
Closed -$9.49K – 1219
2025
Q2 		$9.49K Buy
+75
New +$9.21K ﹤0.01% 1151
2024
Q3 		– Sell
-972
Closed -$134K – 1231
2024
Q2 		$134K Hold
972
– – ﹤0.01% 1178
2024
Q1 		$134K Hold
972
– – ﹤0.01% 1184
2023
Q4 		$132K Hold
972
– – ﹤0.01% 1162
2023
Q3 		$119K Hold
972
– – ﹤0.01% 1176
2023
Q2 		$122K Hold
972
– – ﹤0.01% 1201
2023
Q1 		$126K Hold
972
– – ﹤0.01% 1226
2022
Q4 		$128K Hold
972
– – ﹤0.01% 1253
2022
Q3 		$114K Hold
972
– – ﹤0.01% 1248
2022
Q2 		$115K Hold
972
– – ﹤0.01% 1288
2022
Q1 		$127K Buy
+972
New +$127K ﹤0.01% 1320
2021
Q3 		– Sell
-972
Closed -$159K – 1519
2021
Q2 		$159K Hold
972
– – ﹤0.01% 1365
2021
Q1 		$146K Hold
972
– – ﹤0.01% 1352
2020
Q4 		$147K Hold
972
– – ﹤0.01% 1340
2020
Q3 		$130K Hold
972
– – ﹤0.01% 1226
2020
Q2 		$133K Hold
972
– – ﹤0.01% 1135
2020
Q1 		$109K Hold
972
– – ﹤0.01% 1179
2019
Q4 		$117K Hold
972
– – ﹤0.01% 1200
2019
Q3 		$97K Sell
972
-972
-50% -$102K ﹤0.01% 1191
2019
Q2 		$212K Buy
1,944
+972
+100% +$103K ﹤0.01% 1137
2019
Q1 		$109K Buy
+972
New +$107K ﹤0.01% 1100
2018
Q4 		– Sell
-972
Closed -$119K – 1251
2018
Q3 		$119K Hold
972
– – ﹤0.01% 1166
2018
Q2 		$105K Buy
+972
New +$104K ﹤0.01% 1203
2014
Q4 		– Sell
-17,907
Closed -$1.63M – 1400
2014
Q3 		$1.63M Buy
17,907
+9,000
+101% +$790K ﹤0.01% 938
2014
Q2 		$763K Hold
8,907
– – ﹤0.01% 1015
2014
Q1 		$702K Sell
8,907
-1,740
-16% -$145K ﹤0.01% 1012
2013
Q4 		$806K Sell
10,647
-8,985
-46% -$637K ﹤0.01% 1058
2013
Q3 		$1.37M Buy
+19,632
New +$1.29M ﹤0.01% 973

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Schroder Investment Management Group's IBB Position: Q3 2025 in Review

Schroder Investment Management Group sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 75 shares — an estimated $9.49K sold.

Schroder Investment Management Group first reported a position in IBB in Q3 2013 and held it in 28 quarters. The position peaked at $1.63M in Q3 2014. 804 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Schroder Investment Management Group reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 75 iShares Biotechnology ETF shares in Q3 2025, an estimated $9.49K.
  • Schroder Investment Management Group first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 28 quarters.
  • Schroder Investment Management Group's iShares Biotechnology ETF position peaked at $1.63M in Q3 2014.
  • 804 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Schroder Investment Management Group's 13F filing for Q3 2025, filed 13 Nov 2025.